StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
4
Publishing Date
2023 - 06 - 22
1
2021 - 05 - 04
1
2021 - 04 - 22
1
2021 - 04 - 15
1
Sector
Health technology
4
Tags
Abbvie
7
Active
10
Agreement
10
America
46
Antibiotics
7
Antibody
9
Application
9
Approval
10
Biotech
26
Cancer
54
Care
11
Collaboration
11
Covid
34
Covid-19
25
Device
11
Diabetes
7
Disease
39
Distribution
11
Drug
110
Drug delivery
12
Earnings
7
Ema
7
Europe
17
Expected
28
Fda
14
Food
22
Genetown
9
Global
159
Growing
34
Growth
192
Health
22
Hiv
12
Infection
10
Infections
9
Influenza
9
Iot
19
License
10
Liver
15
Market
447
Merge
11
N/a
792
Nutrition
12
People
16
Pharma
11
Pharmaceuticals
12
Positive
12
Reach
24
Report
140
Research
88
Respiratory
16
Results
19
Risk
8
Set
14
System
11
Technology
23
Therapeutics
84
Therapy
24
Treatment
98
Trial
13
Vaccine
56
Entities
Agenus inc.
1
Curevac n.v.
1
Glaxosmithkline plc
4
Pfizer, inc.
1
Symbols
A
6
ABBV
4
ABCL
4
ABT
5
ADCT
3
AGEN
3
AMGN
6
AMRS
4
ANIX
5
APDN
6
AVGR
5
AVRO
3
AXNX
3
AYTU
3
BDX
5
BGNE
9
BMY
14
BRKR
8
BSX
4
CDNA
6
CODX
4
CSII
3
CSTL
3
EDSA
3
ENDP
4
EPIX
3
EXEL
5
GILD
3
GNPX
3
GSK
4
HOTH
5
IMAB
6
INCY
7
JNJ
58
LEXX
4
LH
4
LLY
17
LPCN
4
MDT
7
MOTS
4
MRK
9
MRNA
13
MS
4
MYGN
4
NAOV
4
NVS
5
OMER
4
PFE
10
PKI
4
PTE
7
QDEL
4
SEEL
6
SNY
36
SNYNF
6
TAK
10
TECH
8
TMO
5
TNXP
4
TWST
9
XNCR
4
Exchanges
Nasdaq
2
Nyse
4
Crawled Date
2023 - 06 - 22
1
2021 - 05 - 04
1
2021 - 04 - 22
1
2021 - 04 - 15
1
Crawled Time
07:00
1
12:15
1
13:00
1
21:00
1
Source
www.biospace.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Product-news
symbols :
GSK
save search
US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices votes to recommend AREXVY for the prevention of RSV disease in adults aged 60 and older with shared clinical decision making
Published:
2023-06-22
(Crawled : 07:00)
- biospace.com/
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
17.33%
|
O:
-1.37%
H:
0.52%
C:
0.03%
AGEN
A
|
$6.44
11.61%
10.4%
1.7M
|
Health Technology
|
251.09%
|
O:
-1.09%
H:
1.65%
C:
-2.2%
disease
control
rsv
ViiV Healthcare initiates rolling submission of new drug application with US FDA for long-acting cabotegravir for prevention of HIV
Published:
2021-05-04
(Crawled : 13:00)
- biospace.com/
PFE
|
News
4
|
$26.32
0.23%
0.0%
24M
|
Health Technology
|
-33.92%
|
O:
0.43%
H:
0.43%
C:
-0.13%
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
9.48%
|
O:
-0.19%
H:
0.29%
C:
-0.27%
new drug
fda
drug
hiv
submission
application
FDA grants accelerated approval for GSK's JEMPERLI (dostarlimab-gxly) for women with recurrent or advanced dMMR endometrial cancer
Published:
2021-04-22
(Crawled : 21:00)
- biospace.com/
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
7.82%
|
O:
-1.15%
H:
0.36%
C:
-0.34%
fda
women
cancer
trial
approval
granted
grant
dostarlimab
CureVac Announces Financial Results and Business Updates for the Fourth Quarter and Full-Year of 2020
Published:
2021-04-15
(Crawled : 12:15)
- biospace.com/
GSK
|
News
|
$41.24
1.6%
0.0%
2.3M
|
Health Technology
|
14.14%
|
O:
4.23%
H:
1.59%
C:
0.08%
CVAC
|
$2.585
2.17%
2.13%
610K
|
Health Technology
|
-97.47%
|
O:
3.26%
H:
2.34%
C:
-1.8%
financial results
results
Gainers vs Losers
78%
22%
Top 10 Gainers
MTTR
|
News
4
|
$4.6
164.37%
62.17%
28M
|
AGBA
|
$2.94
135.2%
57.48%
66M
|
Finance
EDBL
|
News
|
$6.46
71.81%
41.8%
2M
|
MTC
|
$2.25
44.23%
30.67%
6M
|
Technology Services
OPRT
|
News
|
$3.175
41.11%
29.13%
12M
|
Finance
SHIM
|
$3.05
35.56%
26.23%
1.1M
|
HKIT
|
$1.345
31.86%
24.16%
390K
|
Technology Services
ABVC
|
$1.36
30.77%
23.53%
7.4M
|
Wholesale Trade
OST
|
$0.512
28.0%
21.88%
290K
|
POET
|
$1.59
27.2%
21.38%
4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.